Item 5.07. Submission of Matters to a Vote of Security Holders.

At the 2021 Annual Meeting of Stockholders of Aerie Pharmaceuticals, Inc. (the "Company"), held on June 17, 2021, the Company's stockholders considered and voted upon the following proposals, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 27, 2021:





Proposal  1: Elections of Directors.

By vote reflected below, each of the following director nominees was elected to serve on the Board of Directors for a three-year term, or until his successor has been duly elected and qualified.





                                              Votes
          Nominee              Votes For    Withheld    Broker Non-Votes

Mechiel (Michael) M. du Toit 27,716,188 6,163,972 3,476,747


      David W. Gryska          33,075,157    805,003       3,476,747




Proposal 2:   Ratification of the appointment of PricewaterhouseCoopers LLP as the
              Company's independent registered public accounting firm for the fiscal
              year ending December 31, 2021.


By vote reflected below, the appointment of PricewaterhouseCoopers LLP was
ratified.



Votes For    Votes Against   Votes Abstained
36,977,984      356,711          22,212




Proposal  3: To approve, by a non-binding vote, the compensation of the Company's
          named executive officers ("say-on-pay").

By vote reflected below, the Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers.





Votes For    Votes Against   Votes Abstained   Broker Non-Votes
19,277,879    14,399,168         203,113          3,476,747

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses